The physiological functions of apoA2 in lipoprotein metabolism and obesity development are not fully elucidated, but it was shown that apoA2 overexpression exhibits marked hypertriglyceridemia, insulin resistance, increased adiposity, and increased atherosclerosis [31]. The gene discussed is APOA2; the disease is hypertriglyceridemia.